Ad Code

Responsive Advertisement

Novavax Covid Jab Highly Effective, But Not Against South Africa Variant

US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a...

from NDTV News - Special https://ift.tt/36lyTbO
via IFTTT

Post a Comment

0 Comments